DD142049A5 - Verfahren zur herstellung acylierter aminoalkyl-cyanoguanidine mit heterocyclischem rest - Google Patents

Verfahren zur herstellung acylierter aminoalkyl-cyanoguanidine mit heterocyclischem rest Download PDF

Info

Publication number
DD142049A5
DD142049A5 DD79211047A DD21104779A DD142049A5 DD 142049 A5 DD142049 A5 DD 142049A5 DD 79211047 A DD79211047 A DD 79211047A DD 21104779 A DD21104779 A DD 21104779A DD 142049 A5 DD142049 A5 DD 142049A5
Authority
DD
German Democratic Republic
Prior art keywords
groups
group
alkyl
compound
alk
Prior art date
Application number
DD79211047A
Other languages
German (de)
English (en)
Inventor
Bebenburg Walter Von
Norbert Schulmeyer
Istvan Szelenyi
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of DD142049A5 publication Critical patent/DD142049A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD79211047A 1978-02-17 1979-02-15 Verfahren zur herstellung acylierter aminoalkyl-cyanoguanidine mit heterocyclischem rest DD142049A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB636778 1978-02-17

Publications (1)

Publication Number Publication Date
DD142049A5 true DD142049A5 (de) 1980-06-04

Family

ID=9813213

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79211047A DD142049A5 (de) 1978-02-17 1979-02-15 Verfahren zur herstellung acylierter aminoalkyl-cyanoguanidine mit heterocyclischem rest

Country Status (13)

Country Link
US (1) US4256752A (fr)
JP (1) JPS54125666A (fr)
AT (1) ATA123879A (fr)
BE (1) BE874260A (fr)
DD (1) DD142049A5 (fr)
DE (1) DE2905134A1 (fr)
DK (1) DK69379A (fr)
FR (1) FR2417505A1 (fr)
GB (1) GB2017084A (fr)
IL (1) IL56686A0 (fr)
NL (1) NL7901255A (fr)
PL (1) PL115911B1 (fr)
SE (1) SE7901404L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US5081154A (en) * 1984-01-10 1992-01-14 Aktiebolaget Hassle Metoprolol succinate
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
AU2252388A (en) * 1988-05-02 1989-11-29 Zila Pharmaceuticals Compositions and in situ methods for forming films on body tissue
GB0121444D0 (en) * 2001-09-05 2001-10-24 Univ Strathclyde Sensor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
US4060621A (en) * 1972-09-05 1977-11-29 Smith Kline & French Laboratories Limited Pyridyl alkylguanidine compounds
US3979398A (en) * 1973-02-08 1976-09-07 Smith Kline & French Laboratories Limited Sulphoxides
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4104929A (en) * 1977-05-02 1978-08-08 Dana Corporation Shift mechanism
GB1602458A (en) 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
IL56686A0 (en) 1979-05-31
GB2017084A (en) 1979-10-03
FR2417505A1 (fr) 1979-09-14
JPS54125666A (en) 1979-09-29
PL115911B1 (en) 1981-05-30
NL7901255A (nl) 1979-08-21
US4256752A (en) 1981-03-17
ATA123879A (de) 1980-12-15
BE874260A (fr) 1979-08-16
DE2905134A1 (de) 1979-08-23
PL213474A1 (fr) 1980-03-10
DK69379A (da) 1979-08-18
SE7901404L (sv) 1979-08-18

Similar Documents

Publication Publication Date Title
EP0042592B1 (fr) N-hétéroarylalkylènediamines, procédé pour leur préparation et leur utilisation
DE2433105A1 (de) Verfahren zur herstellung von 3iminomethylderivaten von rifamycin sv
DD142049A5 (de) Verfahren zur herstellung acylierter aminoalkyl-cyanoguanidine mit heterocyclischem rest
DE69708340T2 (de) Arylsulfonylimidazolon-derivate als antitumormittel
DE3027106C2 (fr)
DE1445675B2 (de) Pyridylharnstoffe und verfahren zu ihrer herstellung
DE2521709C3 (de) Verfahren zur Herstellung von in 2- und 6- Stellung substituierten 1- Benzoyl-2-phenyl-amino-2-imidazolinderivaten
DE3336225A1 (de) Verfahren zur herstellung von imidazolen und neue zwischenprodukte fuer die verwendung in diesem verfahren
DE3781703T2 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DD216456A5 (de) Verfahren zur herstellung neuer aralkyltriazolverbindungen
EP0293742B1 (fr) Procédé de préparation d'éthers et thioéthers de nitro-4 imidazolyle-5
DE3108753A1 (de) Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
DD141157A1 (de) Verfahren zur herstellung von neuen arylaminoimidazolinderivaten
DE2733952A1 (de) Alpha, omega-diaminoalkylenverbindungen
DE2900504A1 (de) Neue substituierte 4-aminopyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2809798A1 (de) Verfahren zur herstellung von 5-substituierten tetrazolen
DD216011A5 (de) Verfahren zur herstellung eines guanidinabkoemmlings
DE3204074C2 (fr)
DE3107514A1 (de) Neue nitrosoharnstoff-derivate und verfahren zu ihrer herstellung
EP0168607A1 (fr) Acides pyrrolidinecarboxyliques, procédé pour leur fabrication
DE2805827A1 (de) Neue alkanoyl-cyanoguanidine mit einem heterocyclischen rest
DE3200258A1 (de) Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
AT373588B (de) Verfahren zur herstellung von neuen substituierten 1-benzoyl-2-phenylimino-imidazolidinen und von deren salzen
AT214917B (de) Verfahren zur Herstellung neuer Benzimidazole
DE2222471C3 (de) Verfahren zur Herstellung von 1-(Acylamino-aryloxy)-3-aminopropanol-Derivaten sowie deren nicht-toxischen Säureadditionssalzen